Dr Landon MottProcess Development Principal Scientist at Amgen Inc.Speaker
Profile
Landon joined Amgen in 2019 where he now leads a team of upstream and downstream process development scientists to advance next generation modalities through a challenging development landscape. His team’s automation and modelling expertise has enabled timeline savings for early-phase cell line dev, upstream cell culture, as well as purification process development activities.
Agenda Sessions
Chairperson Remarks: Cell Line Development & Engineering
, 11:25amView SessionChairperson Remarks: Cell Line Development & Engineering
, 2:10pmView SessionPANEL DISCUSSION: The Growing Complexity of Biotherapeutics
, 2:30pmView Session